AT299449B - Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen - Google Patents

Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen

Info

Publication number
AT299449B
AT299449B AT1212169A AT1212169A AT299449B AT 299449 B AT299449 B AT 299449B AT 1212169 A AT1212169 A AT 1212169A AT 1212169 A AT1212169 A AT 1212169A AT 299449 B AT299449 B AT 299449B
Authority
AT
Austria
Prior art keywords
benzdiazepine
compounds
new
production
antibiotically effective
Prior art date
Application number
AT1212169A
Other languages
German (de)
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44050780A external-priority patent/JPS4843755B1/ja
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of AT299449B publication Critical patent/AT299449B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT1212169A 1968-12-30 1969-12-30 Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen AT299449B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8369 1968-12-30
JP44050780A JPS4843755B1 (enExample) 1969-06-26 1969-06-26

Publications (1)

Publication Number Publication Date
AT299449B true AT299449B (de) 1972-05-15

Family

ID=26332993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1212169A AT299449B (de) 1968-12-30 1969-12-30 Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen

Country Status (5)

Country Link
AT (1) AT299449B (enExample)
BE (1) BE743875A (enExample)
DE (1) DE1965304A1 (enExample)
FR (1) FR2027356A1 (enExample)
NL (1) NL6919607A (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
ES2260570T3 (es) 1998-08-27 2006-11-01 Spirogen Limited Pirrolobenziodiazepinas dimericas.
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
GB9818732D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collection of compounds
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
ES2398975T3 (es) 2004-03-01 2013-03-25 Spirogen Sàrl Derivados de 11-hidroxi-5H-pirrolo[2,1-c][1,4]benzodiazepin-5-ona como intermedios clave para la preparación de pirrolobenzodiazepinas sustituidas en C2
GB0404577D0 (en) 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
EP1723152B1 (en) 2004-03-09 2015-02-11 Spirogen Sàrl Pyrrolobenzodiazepines
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
MX368648B (es) 2010-04-15 2019-10-09 Seattle Genetics Inc Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
GB201006340D0 (en) 2010-04-15 2010-06-02 Spirogen Ltd Synthesis method and intermediates
CN103068405A (zh) 2010-04-15 2013-04-24 西雅图基因公司 靶向吡咯并苯并二氮杂卓结合物
US9399641B2 (en) 2011-09-20 2016-07-26 Medimmune Limited Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates
AU2012322934B2 (en) 2011-10-14 2016-09-08 Medimmune Limited Pyrrolobenzodiazepines
JP6166728B2 (ja) 2011-10-14 2017-07-19 メドイミューン・リミテッドMedImmune Limited ピロロベンゾジアゼピンの製造に有用な合成方法及び中間体
CA2850373C (en) 2011-10-14 2019-07-16 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
CA2850375C (en) 2011-10-14 2019-07-02 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
CA2850264C (en) 2011-10-14 2019-11-05 Medimmune Limited Pyrrolobenzodiazepines
KR101995620B1 (ko) 2012-10-12 2019-07-03 에이디씨 테라퓨틱스 에스에이 피롤로벤조디아제핀-항체 컨주게이트
PT2906248T (pt) 2012-10-12 2019-03-04 Medimmune Ltd Pirrolobenzodiazepinas e conjugados das mesmas
EP2906297B1 (en) 2012-10-12 2017-12-06 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
WO2014057114A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-anti-psma antibody conjugates
DK2906298T3 (en) 2012-10-12 2018-12-17 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
PT2906253T (pt) 2012-10-12 2018-11-05 Medimmune Ltd Conjugados de anticorpo anti-psma de pirrolobenzodiazepina
DK2839860T3 (da) 2012-10-12 2019-06-17 Medimmune Ltd Pyrrolobenzodiazepiner og konjugater deraf
EP2906249B1 (en) 2012-10-12 2018-06-27 MedImmune Limited Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
BR112015008238A2 (pt) 2012-10-12 2017-11-28 Adc Therapeutics Sarl conjugados de pirrolbenzodiazepina-anticorpo anti-cd22
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
WO2015052534A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
WO2015052535A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN107148285B (zh) 2014-11-25 2022-01-04 Adc治疗股份有限公司 吡咯并苯并二氮杂䓬-抗体缀合物
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
RS61795B1 (sr) 2017-02-08 2021-06-30 Adc Therapeutics Sa Konjugati pirolobenzodiazepin antitela
SMT202200490T1 (it) 2017-04-18 2023-01-13 Medimmune Ltd Coniugati di pirrolobenzodiazepina
WO2018193102A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
KR102442736B1 (ko) 2017-06-14 2022-09-16 에이디씨 테라퓨틱스 에스에이 항-cd19 adc의 투여를 위한 투약량 체제
SI3668874T1 (sl) 2017-08-18 2022-04-29 Medimmune Limited Pirolobenzodiazepinski konjugati
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CN113631560B (zh) 2019-03-15 2025-02-18 麦迪穆有限责任公司 氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361742A (en) * 1964-12-07 1968-01-02 Hoffmann La Roche 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides

Also Published As

Publication number Publication date
DE1965304A1 (de) 1970-07-23
BE743875A (enExample) 1970-05-28
FR2027356A1 (en) 1970-09-25
FR2027356B1 (enExample) 1974-01-11
NL6919607A (enExample) 1970-07-02

Similar Documents

Publication Publication Date Title
AT301020B (de) Verfahren zur Herstellung von neuen α-Amino-cyclohexadienylalkylen-penicillinen und -cephalosporinen
AT301544B (de) Verfahren zur Herstellung von neuen Chromonen
CH513152A (de) Verfahren zur Herstellung von neuen Dibenz-oxepinen, -thiepinen und -azepinen
AT298451B (de) Verfahren zur Herstellung von neuen, basisch substituierten Phenolen
AT308981B (de) Verfahren zur Herstellung von neuen Perhydrobenzindenen
AT287198B (de) Verfahren zur Herstellung von neuen Penicillinen
CH558342A (de) Verfahren zur herstellung von neuen phenolderivaten.
AT295486B (de) Verfahren zur Herstellung von neuen Disulfiden
CH510668A (de) Verfahren zur Herstellung von neuen 1,6-Dimethyl-10a-ergolinderivaten
AT291232B (de) Verfahren zur Herstellung von neuen Indanderivaten
AT293425B (de) Verfahren zur Herstellung von neuen Bisammoniumverbindungen
AT293640B (de) Verfahren zur Herstellung von neuen Oxydo-cardadienoliden und -bufatrienoliden
AT284834B (de) Verfahren zur Herstellung von neuen Triazolyl-cumarinen
CH524630A (de) Verfahren zur Herstellung von neuen 2-Desoxyuridinen
CH525893A (de) Verfahren zur Herstellung von neuen Benzomorphanderivaten
CH523256A (de) Verfahren zur Herstellung von neuen Bisimidazolyl-bisphenylmethanen
CH526530A (de) Verfahren zur Herstellung von neuen Benzofuranderivaten
AT289296B (de) Verfahren zur Herstellung von neuen Penicillinen
CH505121A (de) Verfahren zur Herstellung von neuen Ammoniumverbindungen
AT309703B (de) Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-norsteroiden
CH550202A (de) Verfahren zur herstellung von neuen cephalosporinverbindungen.
AT295144B (de) Verfahren zur Herstellung von neuen, überwiegend linearen Polybiureten
AT294311B (de) Verfahren zur Herstellung von neuen 2-Hydroxy-penamverbindungen
AT290029B (de) Verfahren zur Herstellung von neuen 2-Halogen-18-methyl-1-androstenen
AT289814B (de) Verfahren zur Herstellung von neuen Chinoxalin-di-N-oxyd-lactonen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee